24LBA Safety data from the phase 1b part of the MASTERKEY-265 study combining talimogene laherparepvec (T-VEC) and pembrolizumab for unresectable stage IIIB-IV melanoma

Reinhard Dummer,Antoni Ribas,Igor Puzanov,Olivier Michielin,A. Vanderwalde,R.H.I. Andtbacka,Jonathan Cebon, E. Fernandez,Josep Malvehy,A.J. Olszanski,T.F. Gajewski,John M. Kirkwood,C. Gause,L. Chen,D.R. Kaufman, J. Chou,F.S. Hodi

EUROPEAN JOURNAL OF CANCER（2015）

引用 11|浏览27

暂无评分

关键词

melanoma,pembrolizumab,t-vec

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要